Comments
Loading...

NLS Pharmaceutics Earnings Estimates

NLSPNASDAQ
Logo brought to you by Benzinga Data
$1.51
0.000.00%
At close: -
$1.54
0.031.99%
After Hours: 7:31 PM EDT

NLS Pharmaceutics Earnings Estimates, EPS & Revenue | NASDAQ:NLSP | Benzinga

NLS Pharmaceutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 18
EPS
$-1.940
Quarterly Revenue
$0.00
Annual Revenue
(as of Jun 30)

Analyze the earnings history of NLS Pharmaceutics using advanced sorting and filters.

Get Alert
NLSPNLS Pharmaceutics-$0.32$0.0005/14/2025Get Alert
NLSPNLS Pharmaceutics-$0.20-$1.94$0.00$0.0010/18/2024Get Alert
NLSPNLS Pharmaceutics-$0.84-$0.32$0.00$0.0005/15/2024Get Alert
NLSPNLS Pharmaceutics-$0.54-$0.20$0.00$0.0012/06/2023Get Alert
NLSPNLS Pharmaceutics-$1.00-$0.84$0.00$0.0005/05/2023Get Alert
NLSPNLS Pharmaceutics-$0.42-$0.54$0.00$0.0010/11/2022Get Alert
NLSPNLS Pharmaceutics-$0.41-$1.00$0.00$0.0003/24/2022Get Alert
NLSPNLS Pharmaceutics-$0.42$0.0009/28/2021Get Alert
NLSPNLS Pharmaceutics-$0.80-$0.41$0.0005/14/2021Get Alert

NLS Pharmaceutics (NLSP) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %

NLS Pharmaceutics (NLSP) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is NLS Pharmaceutics (NASDAQ:NLSP) reporting earnings?

A

NLS Pharmaceutics (NLSP) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on October 18, 2024 for H1.

Q

What were the latest earnings per share (EPS) for NLS Pharmaceutics (NASDAQ:NLSP)?

A

The Actual EPS was $-1.94, which missed the estimate of $0.00.

Q

What were NLS Pharmaceutics’s (NASDAQ:NLSP) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.